Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin

Title
Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 21, Issue 5, Pages 1161-1171
Publisher
American Association for Cancer Research (AACR)
Online
2014-12-27
DOI
10.1158/1078-0432.ccr-14-1088

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now